http://www.ocimumbio.com/web/news/press.asp Ocimum Biosolutions - Press Releases en-us Tue, 14 July 2009 09:30:00 GMT Tue, 14 July 2009 09:30:00 GMT Ocimum Biosolutions pr@ocimumbio.com webmaster@ocimumbio.com 1440 Patent for method and system for managing and querying gene expression data according to quality. Ocimum Biosolutions has announced issuance of United States Patent No. 7,558,411 B2 for developing a method and system for managing and querying gene expression data according to quality. http://www.ocimumbio.com/web/news/subnews.asp?nid=354 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=354 Tue, 14 July 2009 09:30:00 GMT Launches expanded range of genomics services from its Netherlands facility. IJsselstein, The Netherlands, May 5, 2009: In line with its strategic objective to build a global network of service centers in close proximity to leading genomics researchers, Ocimum Biosolutions B.V. today announced the launch of genomic services on Affymetrix platform from Europe. Initially Ocimum will service Gene Expression studies on the Affymetrix platform from its facility at IJsselstein, The Netherlands. Within a couple of months, it will launch the entire bouquet of services from its IJsselstein facility. http://www.ocimumbio.com/web/news/subnews.asp?nid=340 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=340 Tue, 05 May 2009 05:30:00 GMT Launches a microarray based test updated with the latest H1N1 sequences.

Hyderabad, India, May 4, 2009: Ocimum Biosolutions announced the launch of a microarray based test (research use only) for the latest version of the H1N1 flu. The company reported that it updated its custom chip probes using sequence information from the latest strain of the swine flu from the NCBI site. Most of these sequences have been submitted worldwide in the past 96 hours. The CDC and US Food and Drug Administration have authorized the emergency use of an RT-PCR based molecular diagnostic assay to identify cases of swine flu in the current outbreak in the US. http://www.ocimumbio.com/web/news/subnews.asp?nid=339 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=339 Mon, 04 May 2009 10:30:00 GMT Stimulus package for its complete Biotracker biobanking solution available in US and Canada for USD 75k and in Europe for Euro 58K

Ocimum Biosolutions today unveiled its Biobanking Stimulus Package by offering its complete Biotracker(tm) Biobanking Solution for USD75,000 (applicable in US and Canada). A similar Stimulus Package is also available for European countries for EURO 58,000. The Biobanking Stimulus Package includes Ocimum’s world-class Biotracker(tm) for Biobanking software, Implementation, Training, and the First year of Support & Maintenance. The package is offered at a fixed price with guaranteed on-time delivery. http://www.ocimumbio.com/web/news/subnews.asp?nid=337 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=337 Thu, 05 Mar 2009 06:30:00 GMT Hyderabad, India, January 27, 2009: In an unrivaled move, Ocimum Biosolutions, a leading integrated genomics company, based in Hyderabad, India, is unveiling its Biotracker™ R&D Life Science LIMS technology to its customers and partners. In the latest Biotracker™ 4.1 release, all the LIMS methods are now accessible through advanced Web Services based API, as well as a Java based API. The Biotracker™ application program interface is a robust set of routines, protocols, and tools useful to extend the functionality of LIMS system to support the changing needs in drug research and development Environment. ‘What this means is that genomics universities and companies can advance Biotracker™ to support new biotech platforms and core competency advancements”, says Ms. Anuradha Acharya, Founder & CEO of Ocimum Biosolutions. “At Ocimum, we provide global solutions to enable biological decision making, perform biological services, and supply biological molecules.” http://www.ocimumbio.com/web/news/subnews.asp?nid=335 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=335 Tue, 27 Jan 2009 06:30:00 GMT Gaithersburg, Maryland, United Stated and Hyderabad, Andhra Pradesh, India: January 23, 2009: Clarmon Corporation announced today the release of QAvalid 2.0, the latest version of its leading validation and compliance management system. http://www.ocimumbio.com/web/news/subnews.asp?nid=334 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=336 Fri, 23 Jan 2009 06:30:00 GMT Hyderabad, India and Gaithersburg, MD, January 6, 2009: Ocimum Biosolutions, a leading integrated genomics company, based in Hyderabad, India, announced today it is now an authorized provider for services using NuGEN Ovation(R) Systems for sample preparation. This partnership enables researchers in India, for the first time, to conduct gene expression profiling from a wide range of clinically relevant sample types, such as small, compromised, or formalin-fixed, paraffin-embedded (FFPE) tissues. http://www.ocimumbio.com/web/news/subnews.asp?nid=334 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=334 Tue, 06 Jan 2009 06:30:00 GMT Hyderabad, Andhra Pradesh, India | Gaithersburg, Maryland, USA. December 16, 2008 - Ocimum Biosolutions, a leading integrated genomics company, today announced that Anuradha Acharya, CEO has been awarded the Astia Life Science Innovators Award and the Biospectrum Entrepreneur of the Year award. http://www.ocimumbio.com/web/news/subnews.asp?nid=333 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=333 Tue, 16 Dec 2008 06:30:00 GMT Gaithersburg, MD, November 25, 2008 - Ocimum Biosolutions is proud to announce its partnership with Clarmon Corporation to distribute, implement and support its Compliance Management Solution, QAvalid™. Ocimum Biosolutions’ extensive knowledge of Computer Systems Validation requirements and processes as well as its extensive understanding of pharmaceutical and biotechnology laboratories combined with Clarmon's unique solution, QAvalid™, creates a valuable partnership for regulated industries seeking effective and efficient validation solutions for their laboratory systems. "Our partnership with Clarmon will provide a true value-added solution to our customers who are seeking to improve the efficiency and effectiveness of their Computer Systems Validation projects", said Anuradha Acharya, CEO of Ocimum Biosolutions. "By leveraging our own experiences in validating our laboratory software systems with the Clarmon QAvalid™ solution, we bring real-life expertise to this partnership", Ms. Acharya added. "We are very pleased to begin this partnership with Ocimum Biosolutions, whose first-hand experience with our Compliance Management Solution as well as their world-class sales and technical staff will provide a very powerful experience to our ever-growing global customer base," said Jan Olsen, Chief Operating Officer of Clarmon Corporation. "Ocimum Biosolutions and Clarmon together will revolutionize the computer systems validation process to enable regulated industries reduce their costs in these challenging economic times, while simultaneously improving the quality and consistency of their validation documentation." http://www.ocimumbio.com/web/news/subnews.asp?nid=329 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=329 Tue, 25 Nov 2008 06:30:00 GMT Hyderabad, Andhra Pradesh, India, November 20, 2008 - Ocimum Biosolutions today announced the launch of sequencing services from its India facility. Using the gold standard 96-capillary 3730xl DNA Analyzer, Ocimum would provide various DNA analysis applications such as microsatellites, AFLP, SNP analysis, BAC fingerprinting, mutation detection, resequencing, LOH (loss of heterozygosity) and traditional DNA sequencing for animal, plant, and microbial genomes. The DNA sequencing services offered by Ocimum Biosolutions are: Shot Gun Sequencing (BACs/Cosmids), Primer Walking, Re-sequencing (SNP profiling), high throughput sequencing and bacterial identification. Ocimum’s team of trained bioinformaticians, sequencing experts, and statisticians help in achieving optimized assembly, accurate SNP analysis and better base calling. Ocimum also offers assistance for genome sequence annotation and analysis, mutational analysis, and confidential sequencing data management. http://www.ocimumbio.com/web/news/subnews.asp?nid=328 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=328 Thu, 20 Nov 2008 06:30:00 GMT The winners of the maiden edition of the Genomic Pioneer Awards (GPA) were announced at the HUGO’s 13th International Meeting on the Human Genome on September 30, 2008. The Genomic Pioneers Award winners are Dr. Sylvie Chauvaux, Asst Professor, Institut Pasteur, Paris for Europe; Dr. Srikanta Kumar Rath, Scientist, Genotoxicity Laboratory, Central Drug Research Institute for India; and Dr. Juergen Pipper, Senior Scientist, Institute of Bioengineering and Nanotechnology, Singapore for the Asia-Pacific region. http://www.ocimumbio.com/web/news/subnews.asp?nid=327 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=327 Wed, 22 Oct 2008 06:30:00 GMT Ocimum Biosolutions has announced issuance of United States Patent No. 7,428,554 which covers the company's proprietary system and method for determining matching patterns within gene expression data and US Patent No. 7426441, which covers methods for determining renal toxins. http://www.ocimumbio.com/web/news/subnews.asp?nid=326 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=326 Wed, 15 Oct 2008 06:30:00 GMT Gene Logic (An Ocimum Biosolutions Company) has entered into a Strategic Alliance with deSciner(tm) Business Network to create an interactive genomics information resource. Both organizations will work together to create a unique knowledge resource in genomics called 'Genomics Gateway'. The vision of this partnership is to present applications of genomics in pursuit of improved and affordable healthcare and therapeutics. The Gateway will feature leading scientists, developments and progress in this area through webinars, interactive interviews, and blogs amongst other vehicles. http://www.ocimumbio.com/web/news/subnews.asp?nid=324 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=324 Fri, 10 Oct 2008 05:00:00 GMT Gaithersburg, Md., US and Hyderabad, India – Monday, September 08, 2008 - Ocimum Biosolutions today announced the issuance of U.S. Patent No. US 7,415,358 B2 entitled ‘Molecular toxicology modeling’. The patent describes elucidation of the global changes in gene expression and identification of toxicity markers in tissues or cells exposed to a known renal toxin. The genes can be used as toxicity markers in drug screening and toxicity assays. The invention includes a database of genes characterized by toxin-induced differential expression that is designed for use with microarrays and other solid-phase probes. http://www.ocimumbio.com/web/news/subnews.asp?nid=319 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=319 Mon, 08 Sep 2008 05:00:00 GMT Ocimum Biosolutions has announced a first of its kind award that recognizes the trailblazing research innovations in the genomics space. The award would be known as the Genomic Pioneers Award. The purpose of the Genomic Pioneers Award is to recognize excellence and outstanding contribution to the field of genomics using integrated state-of-the-art approaches. http://www.ocimumbio.com/web/news/subnews.asp?nid=317 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=317 Thu, 14 Aug 2008 05:00:00 GMT IJsselstein, The Netherlands and Hyderabad, India – Tuesday, August 12, 2008 — Isogen Biosolutions B. V. has rebranded itself as Ocimum Biosolutions B. V. The aim of the rebranding exercise is to tap the emerging opportunities and need for globalized solutions in Genomics. This represents a significant milestone in company’s history as the company hones its position as the premier integrated global genomics solutions provider. http://www.ocimumbio.com/web/news/subnews.asp?nid=315 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=315 Tue, 12 Aug 2008 05:00:00 GMT GAITHERSBURG, MD and SANTA CLARA, Calif., July 14, 2008 —Gene Logic (An Ocimum Biosolutions Company) and Agilent Technologies today announced that Gene Logic has been reappointed as a Certified Microarray Service Provider for Agilent gene expression microarrays. http://www.ocimumbio.com/web/news/subnews.asp?nid=311 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=311 Mon, 14 Jul 2008 07:00:00 GMT Hyderabad, India — April 22, 2008 — Ocimum Biosolutions, a leading provider of integrated genomics solutions, has announced the release of Genowiz™ 4.0, a comprehensive solution for gene expression analysis. The latest version makes the process of microarray data analysis simpler with a host of features such as AutoGuide to execute automated work flows for analyzing data, addition of organisms/genomes, automatic update of annotations, PLIER algorithm, data export in different formats, box plots and enhanced scatter plots. http://www.ocimumbio.com/web/news/subnews.asp?nid=307 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=307 Tue, 22 Apr 2008 10:00:00 GMT GAITHERSBURG, MD, USA | Hyderabad, India — January 28, 2008 — Gene Logic, an Ocimum Biosolutions company, announced today that it has entered into an agreement with the United States Environmental Protection Agency (EPA) National Center for Computational Toxicology (NCCT) providing access to Gene Logic’s proprietary Genesis Enterprise System® and GX® Connect software and relevant portions of the ToxExpress® System and BioExpress® System. The NCCT will use the data and software to assist in development of the agency’s ToxCast™ program, exploring strategies and methods to screen large numbers of chemicals for potential toxicity. http://www.ocimumbio.com/web/news/subnews.asp?nid=300 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=300 Mon, 28 Jan 2008 08:30:00 GMT Ocimum Biosolutions (Ocimum) is pleased to announce that it has been rated as the top vendor in Bioinformatics by a ValueNotes/KnowGenix research report - Bioinformatics Outsourcing in Life Sciences - India Opportunity. The report provides an incisive analysis of the Indian vendor space, and aims to provide insights into industry practices and trends, and the emerging opportunity in bioinformatics outsourcing/ off-shoring. This study used a proprietary methodology to rate bioinformatics vendors in India. The vendor rating is based on weighted averages of various quantitative and qualitative factors, including reputation, size, service focus, financial strength, partnerships, recognition and certifications. http://www.ocimumbio.com/web/news/subnews.asp?nid=296 Ocimum Biosolutions Press Release http://www.ocimumbio.com/web/news/subnews.asp?nid=296 Thu, 03 Jan 2008 08:30:00 GMT Ocimum Biosolutions (Ocimum) is pleased to announce that it has raised capital from Kubera Cross Border Fund (KUBC) for an equity investment of up to US$17 million (including the pro rata investment by affiliates of Kubera Partners, LLC, the Investment Manager of KUBC). Ocimum Biosolutions also announced that it has successfully closed the acquisition of the genomics division of Gene Logic and will retain the Gene Logic name and continue to service customers from Gaithersburg. http://ocimumbio.com/web/news/subnews.asp?nid=289 Ocimum Biosolutions Press Release http://ocimumbio.com/web/news/subnews.asp?nid=289 Mon, 17 Dec 2007 08:30:00 GMT http://www.ocimumbio.com/web/images/new/ocimumbio.gif http://www.ocimumbio.com/web/news/press.asp